Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00316160
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2006-04-18
Brief Title:
Sexual Functioning Study With Antidepressants
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Twelve-week Multi-center Randomized Double-blind Double-dummy Parallel-group Active Controlled Escalating Dose Study to Compare the Effects on Sexual Functioning of Bupropion Hydrochloride Extended-release WELLBUTRIN XL 150-450 mgDay and Extended-release Venlafaxine EFFEXOR XR 75-225 mgDay in Subjects With Major Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Effects of two depression medication on sexual functioning
Detailed Description:
A Twelve-week Multi-center Randomized Double-blind Double-dummy Parallel-group Active controlled Escalating Dose Study to Compare the Effects on Sexual Functioning of Bupropion Hydrochloride Extended-release WELLBUTRIN XL 150-450 mgday and Extended-release Venlafaxine EFFEXOR XR 75-225 mgday in Subjects with Major Depressive Disorder
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None